A number of recent medical reports have linked high doses of intravenous bisphosphonates given to patients for the treatment of multiple myeloma, breast cancer or other cancers, to a condition […]

Chilliwack General Hospital, BC Brookfield Chair in Fracture Prevention funds new Fracture Liaison Service Program in Chilliwack, BC Chilliwack General Hospital is thrilled to launch a new Fracture Liaison Service […]

No link between the use of bisphosphonates and the risk of cancer of the esophagus or stomach has also been noted in a recent large study from the UK. This […]

New FLS sites in BC and PEI The ongoing collaboration between The Brookfield Chair in Fracture Prevention and Osteoporosis Canada has resulted in a new program BreakFree – resulting in […]

Osteoporosis does not cause pain. It is a broken bone (fracture) caused by the disease that may cause pain. In fact, osteoporosis has been called “the silent thief” because you […]

We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]

A recently released Canadian research study confirms what has been shown in past preliminary studies; – inflammation of the eye as a possible side effect of bisphosphonate therapy is very […]

Anti-Racism Statement Anti-Racism Statement Osteoporosis Canada is committed to the removal of anti-Black systemic barriers negatively affecting the lives of Black Canadians. Osteoporosis Canada is committed to anti-racism and anti-oppression, […]

Fracture Risk Scale An innovative tool for assessing & managing fracture risk in long-term care Did you know? WHY IS PREVENTING FRACTURES IN LONG-TERM CARE IMPORTANT? The fracture rate in […]